Seeking Alpha

Seeking Alpha Portfolio App for iPad

Amy Baldwin

Amy Baldwin picture

Profile

Send Message

View as an RSS Feed

View Amy Baldwin's Articles BY TICKER:

Genomic Health's New Prostate Test May Extend The Stock's Upward Climb
on Wed, May 15 • MYGN, GHDX • Comment!
Once Heralded Dendreon May Be Approaching The End Of Its Financial Road
on Tue, May 14 • DNDN • 23 Comments
Cardinal Health Looks Strong, Beats Earnings Estimates By 25%
on Mon, May 6 • CAH • Comment!
AT&T's CAPEX News Flies Under The Radar
on Fri, Apr 26 • ALU, ERIC, INFN • 6 Comments
2 Undervalued Immunotherapy Picks
on Mon, Apr 15 • IMUC, ONCS.OB • 28 Comments
BSD Medical News To Create A Spark
on Thu, Apr 11 • CLSN, DCTH, ONCS.OB • 14 Comments
A Look At One Of The Fastest Growing Industries In The Market And How To Benefit
on Mon, Apr 8 • APHY.OB, CVS, TTNP.OB • 5 Comments
Galena Biopharma: Will Developments Continue In 2013?
on Wed, Apr 3 • GALE • 3 Comments
Following The Smart Money In The Intellectual Property Battle
on Thu, Feb 28 • VRNG, SPEX, PRKR • 41 Comments
3 Cutting Edge Cancer Therapies May Target Investor Portfolios To Yield Gains
on Mon, Feb 11 • ONCS.OB, DNDN, SGEN • 6 Comments
Profit Growth On The Horizon For Investors Of 3 Companies Advancing Regenerative Medicine
on Mon, Jan 28 • BAX, CYTX, NBS • 6 Comments
With Osiris Overvalued, NeoStem Is A Better Buy
on Wed, Jan 2 • OSIR, NBS • 14 Comments
Sprint/Clearwire Negotiations Might Not Be A Pretty Picture
on Mon, Dec 17, 2012 • CLWR, S • 18 Comments
Galena Biopharma: Recent Developments Paint A Picture Of The Year Ahead
on Tue, Dec 11, 2012 • TEVA, GALE • 23 Comments
4 Speculative Investments You Might Want To Consider
on Mon, Nov 19, 2012 • DNDN, ONCS.OB, PPHM • 12 Comments
NeoStem to Create Value with Billion Dollar Potential
on Wed, Nov 7, 2012 • OSIR, CUR, STEM • 35 Comments
Possible Reverse Split Should Be The Catalyst Needed To Take NeoStem Shares Higher
on Tue, Oct 23, 2012 • BZH, CYCC, NBS • 33 Comments
5 Big Time Biotech Movers On Wednesday
on Thu, Oct 18, 2012 • ARNA, GALE, ITMN • 5 Comments
A Close Look At Home Depot: Cautiously Optimistic Outlook
on Sun, Sep 30, 2012 • LOW, HD • 5 Comments
The Promising, Cheap, And Growing Cell Therapy Arena Continues To Outperform The Market
on Mon, Sep 24, 2012 • CUR, STEM, NBS • 16 Comments
A Gold Mine In Biotechnology: The Companies Poised To Benefit
on Tue, Sep 4, 2012 • GALE, IMUC, CLDX • 12 Comments
Biotech: Mega-Caps Show Investors The Way
on Wed, Aug 29, 2012 • AMGN, GILD, NBS • 2 Comments
Digging Deeper Into Less-Invasive Cancer Treatment Investments
on Mon, Aug 20, 2012 • ANGO, BSX, ONCS.OB • 1 Comment
Dendreon Approaching End Of Road, While Other Immunotherapies Thrive
on Wed, Aug 1, 2012 • DNDN, GALE • 21 Comments
Are Stem Cells Becoming The Next Bull Market In The Biotech Space?
on Mon, Jul 30, 2012 • STEM, NBS, OSIR • 13 Comments
5 Momentum Stocks With Pullbacks That Could Be Your Opportunity
on Thu, Jul 26, 2012 • ARNA, QCOR, IMUC • 55 Comments
Heavy Volume May Mean Heavier Profits In Small Biopharmaceutical Stocks
on Mon, Jul 23, 2012 • ARNA, BMTI, NBS • 17 Comments
Is Netflix A Good Buy At This Time?
on Sun, Jul 8, 2012 • NFLX • 13 Comments
Baxter, NeoStem Duel For Next-Gen Heart Disease Stem Cell Therapy
on Tue, Jul 3, 2012 • BAX, NBS, DNDN • 4 Comments
Is Arena's Share Price Too High?
on Sun, Jun 24, 2012 • CHTP, ARNA • 59 Comments
4 Stocks That Could Trade Higher In The Coming Weeks
on Mon, Jun 18, 2012 • CLDX, GALE, ONTY • 3 Comments
ASCO With Upgrades: Create Catalysts For Growth
on Tue, Jun 5, 2012 • BMY, IMGN, JNJ • 5 Comments